Focus on HIV Care

Back to articles

Two new classes of HIV drugs show promise

KEY POINT

Two new antiretroviral drugs, each representing a new drug class, could be approved by FDA by years’ end. The new drugs are the biggest advance in years and will be particularly useful in patients with infections of multidrug-resistant HIV.